TuesdayFeb 26, 2008 5:05 am
There are many superficial reasons to bypass this stock since investors have so many choices within the Healthcare sector. However, a full appreciation of the versatile know-how cultivated by this company will show that the stock represents extraordinary value compared to its peers in the Biotechnology and Drugs industry. The company is active in a wide array of cutting-edge technologies for its size, but the present value of its formulation products are the most attractive. The company has developed a proprietary way of delivering drugs through human skin. Using patches is both convenient as well as suitable for avoiding undesirable…
Continue Reading